AQST – aquestive therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "buy" rating re-affirmed by analysts at Alliance Global Partners.
Aquestive Therapeutics, Inc. (NASDAQ: AQST) was given a new $7.00 price target on by analysts at Raymond James.
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Form 8-K Aquestive Therapeutics, For: Apr 01
Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: TOTH A ERNEST JR
Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: Kraus Carl N
Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: Jung Cassie
Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: Wargacki Stephen
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.